3 Things About Bristol-Myers Squibb That Smart Investors Know

When it comes to large and fairly complicated companies such as Bristol-Myers Squibb, (NYSE: BMY), the most knowledgeable investors tend to see a lot of things that casual observers miss. With that perspective in hand, let's explore three less-than-obvious things about Bristol-Myers that smart investors probably know, so that you'll have the benefit of their observations. Smart investors appreciate that Bristol-Myers isn't going to be expanding very much in the near term as a result of one of its big-earning medicines losing its exclusivity protections.